HK1007060A1 - Ulmwh (ultra-low-molecular weight heparin) for treating asthma. - Google Patents

Ulmwh (ultra-low-molecular weight heparin) for treating asthma.

Info

Publication number
HK1007060A1
HK1007060A1 HK98106409A HK98106409A HK1007060A1 HK 1007060 A1 HK1007060 A1 HK 1007060A1 HK 98106409 A HK98106409 A HK 98106409A HK 98106409 A HK98106409 A HK 98106409A HK 1007060 A1 HK1007060 A1 HK 1007060A1
Authority
HK
Hong Kong
Prior art keywords
ulmwh
ultra
low
molecular weight
weight heparin
Prior art date
Application number
HK98106409A
Other languages
English (en)
Inventor
Tahir Ahmed
Samuel Broder
John K Whisnant
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of HK1007060A1 publication Critical patent/HK1007060A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
HK98106409A 1995-08-18 1998-06-24 Ulmwh (ultra-low-molecular weight heparin) for treating asthma. HK1007060A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/516,786 US5690910A (en) 1995-08-18 1995-08-18 Method for treating asthma
PCT/US1996/013133 WO1997006783A1 (fr) 1995-08-18 1996-08-13 Procede et composition de traitement de l'asthme

Publications (1)

Publication Number Publication Date
HK1007060A1 true HK1007060A1 (en) 1999-04-01

Family

ID=24057086

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106409A HK1007060A1 (en) 1995-08-18 1998-06-24 Ulmwh (ultra-low-molecular weight heparin) for treating asthma.

Country Status (22)

Country Link
US (1) US5690910A (fr)
EP (1) EP0844869B1 (fr)
JP (1) JP3263723B2 (fr)
KR (1) KR100451901B1 (fr)
AR (1) AR003271A1 (fr)
AT (1) ATE300938T1 (fr)
AU (1) AU701691B2 (fr)
CA (1) CA2229060A1 (fr)
CZ (1) CZ292134B6 (fr)
DE (1) DE69635023T2 (fr)
DK (1) DK0844869T3 (fr)
ES (1) ES2244974T3 (fr)
HK (1) HK1007060A1 (fr)
HU (1) HUP9901614A3 (fr)
IL (1) IL123166A (fr)
NZ (2) NZ315275A (fr)
PL (1) PL186912B1 (fr)
PT (1) PT844869E (fr)
SK (1) SK282759B6 (fr)
UA (1) UA62919C2 (fr)
WO (1) WO1997006783A1 (fr)
ZA (1) ZA966838B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
SI1124563T1 (en) * 1998-10-30 2005-02-28 Ivax Research, Inc. Methods and compositions for the prevention of tolerance to bronchodilators
US6235725B1 (en) * 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2527853T3 (es) 2000-03-08 2015-01-30 Massachusetts Institute Of Technology Heparinasa III y sus usos
EP1292314A2 (fr) * 2000-05-23 2003-03-19 The Trustees of Columbia University in the City of New York Procede de traitement des troubles respiratoires associes a une lesion de la fibre elastique pulmonaire
US7083937B2 (en) 2000-09-12 2006-08-01 Massachusetts Institute Of Technology Methods and products related to the analysis of polysaccarides
CA2423469A1 (fr) * 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Procedes et produits associes a l'administration pulmonaires de polysaccharides
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
PL1791542T3 (pl) 2004-08-23 2015-11-30 Mannkind Corp Sole diketopiperazyny do dostarczania leków
AU2005282065B2 (en) * 2004-09-10 2013-02-07 Pharmaorigin Aps Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
AU2006290870B2 (en) 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
EP2497484A3 (fr) 2006-02-22 2012-11-07 MannKind Corporation Procédé pour améliorer les propriétés pharmaceutiques de microparticules comprenant de la dicétopipérazine et un agent actif
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2205642B1 (fr) * 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Compositions de polysaccharides non anticoagulants
US8569262B2 (en) * 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2570147T3 (da) 2008-06-13 2018-01-29 Mannkind Corp Tørpulverinhalator og system til lægemiddelindgivelse
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (fr) 2009-03-11 2017-06-27 Mannkind Corporation Appareil, systeme et procede de mesure de resistance d'un inhalateur
US8734845B2 (en) 2009-06-12 2014-05-27 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (fr) 2009-11-03 2011-05-12 Mannkind Corporation Appareil et methode de simulation d'efforts d'inhalation
CA2781923C (fr) * 2009-12-03 2018-08-14 Opko Health, Inc. Formulations de disaccharides hypersulfates
WO2011130697A2 (fr) 2010-04-16 2011-10-20 Momenta Pharmaceuticals, Inc. Ciblage tissulaire
CN103096870B (zh) 2010-06-17 2017-04-19 动量制药公司 调节毛发生长的方法和组合物
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
RU2528093C2 (ru) * 2010-07-21 2014-09-10 Олег Ильич Эпштейн Фармацевтическая композиция и способ лечения острых и хронических заболевания дыхательной системы и синдрома кашля
JP2014500863A (ja) * 2010-10-29 2014-01-16 オプコ ヘルス インコーポレイテッド エラスターゼ関連障害を治療するための高硫酸化二糖
MY180552A (en) 2011-04-01 2020-12-02 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
WO2013063160A1 (fr) 2011-10-24 2013-05-02 Mannkind Corporation Procédés et compositions pour traiter la douleur
CA2878457C (fr) 2012-07-12 2021-01-19 Mannkind Corporation Systemes et procedes de liberation de medicament en poudre seche
WO2014066856A1 (fr) 2012-10-26 2014-05-01 Mannkind Corporation Compositions et procédés de vaccin antigrippal inhalable
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
CA2910837A1 (fr) 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Compositions pharmaceutiques
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
CA2920488C (fr) 2013-08-05 2022-04-26 Mannkind Corporation Appareil d'insufflation et procedes
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3500583A1 (fr) 2016-08-16 2019-06-26 OPKO Pharmaceuticals, LLC Disaccharides heptasulfatés purs à biodisponibilité orale améliorée

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE134509T1 (de) * 1991-06-10 1996-03-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
WO1993019734A1 (fr) * 1992-04-02 1993-10-14 Baker Norton Pharmaceuticals, Inc. Procede et composition de traitement de l'asthme provoque par un antigene et par l'effort

Also Published As

Publication number Publication date
HUP9901614A2 (hu) 1999-09-28
AR003271A1 (es) 1998-07-08
PL324970A1 (en) 1998-06-22
AU6694596A (en) 1997-03-12
SK17298A3 (en) 1998-09-09
JPH11511196A (ja) 1999-09-28
DE69635023T2 (de) 2006-05-24
SK282759B6 (sk) 2002-12-03
DE69635023D1 (de) 2005-09-08
WO1997006783A1 (fr) 1997-02-27
CA2229060A1 (fr) 1997-02-27
EP0844869A4 (fr) 2003-04-09
UA62919C2 (en) 2004-01-15
DK0844869T3 (da) 2005-12-12
ATE300938T1 (de) 2005-08-15
CZ48198A3 (cs) 1998-11-11
NZ337996A (en) 2001-04-27
AU701691B2 (en) 1999-02-04
PT844869E (pt) 2005-10-31
EP0844869A1 (fr) 1998-06-03
JP3263723B2 (ja) 2002-03-11
KR19990037688A (ko) 1999-05-25
PL186912B1 (pl) 2004-03-31
EP0844869B1 (fr) 2005-08-03
US5690910A (en) 1997-11-25
ZA966838B (en) 1997-02-19
MX9801165A (es) 1998-07-31
CZ292134B6 (cs) 2003-08-13
IL123166A0 (en) 1998-09-24
IL123166A (en) 2002-07-25
HUP9901614A3 (en) 2000-04-28
KR100451901B1 (ko) 2005-09-12
ES2244974T3 (es) 2005-12-16
NZ315275A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
HK1007060A1 (en) Ulmwh (ultra-low-molecular weight heparin) for treating asthma.
ZA966777B (en) Inhaler.
PH30791A (en) Fibre treatment method.
ZA963694B (en) Methods for inhibiting bone loss.
MX213417B (es) Fenilpiridazinonas.
HUP9802978A3 (en) Method for preparing 1,1,1,3,3-pentafluoropropane
PL315020A1 (en) Capsulation process
ZA961955B (en) Indazolecarboxamides.
SG50401A1 (en) 2,9-Disubstituted purin-6-ones
ZA966081B (en) Adsorption process.
ZA979731B (en) Treatment of asthma.
AU4988096A (en) Non-anticoagulant heparinoids for treating hypovolemic shock
ZA964778B (en) Methods for minimizing bone loss.
ZA969966B (en) Cutting apparatus.
GB2288309B (en) Cigarette weight control.
EP0679810A3 (fr) Appareil à spirales.
GB2298260B (en) Vibration-damping link
EP0678341A3 (fr) Appareil d'enduction.
PL327319A1 (en) Woodworking process
AU6455794A (en) Organopolysiloxanes containing substituted 1,3,5-triazine units
LT97106A (en) 14appha, 17alpha-c2-bridged 19-norprogesterone derivatives
EP0678339A3 (fr) Appareil d'enduction.
ZA9610458B (en) Novel method.
ZA964681B (en) Methods for minimizing bone loss.
NZ320971A (en) Orthosomycins from micromonospora carbonacea

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20160812